The guidances issued today by the FDA are part of a larger initiative by the administration to increase patient access to high-quality generics.
Biopharma companies invested a total of $71.4 billion in research and development in 2017, up from $65.5 billion in 2016 and a record high.
Chris Collins, the United States Representative for New York’s 27th congressional district, has been arrested by the FBI on charges of insider trading.
Biopharma companies can balance competing demands from patients, investors, and regulators by keeping their focus on the science.
Your best weapon to defeat the beast known as cancer is early detection. So, why is funding so focused on finding a “cure,” instead of screening?
The increasing cost of Type 1 diabetes, one of the most common serious chronic diseases, has created heavy financial burdens for families, with insulin prices more than doubling in the past decade.
Take a look at highlights from 15 years of changes in biopharmaceutical manufacturing.
All 10 regions ranked have significant assets that make them attractive to biopharma researchers, executives, and investors.
The arrival of Radicava for ALS marks the first new drug in the market for this rare disease since 1995.